Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519

被引:37
作者
Rudolph, C
Steinemann, D
von Neuhoff, N
Gadzicki, D
Ripperger, T
Drexler, HG
Mrasek, K
Liehr, T
Claussen, U
Emura, M
Schrock, E
Schlegelberger, B
机构
[1] Hannover Med Sch, Inst Cell & Mol Pathol, D-30625 Hannover, Germany
[2] DSMZ, German Collect Microorg & Cell Cultures, Braunschweig, Germany
[3] Univ Jena, Inst Human Genet & Anthropol, D-6900 Jena, Germany
[4] Tech Univ, Fac Med, Inst Clin Genet, Dresden, Germany
关键词
D O I
10.1016/j.cancergencyto.2004.01.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Combining fluorescence R-banding, fluorescence in situ hybridization and spectral karyotyping allowed us to precisely define chromosomal breakpoints, gains, losses and a newly detected amplification in the human mantle cell lymphoma (MCL) cell line GRANTA-519. GRANTA-519 is characterized by the t(11;14)(q13;q32) resulting in overexpression of cyclin D1, a key player in cell cycle control. Hitherto unresolved complex rearrangements involve 1p, 1q, 3cen, 9p, 11q, 12p, 12q, 16p, 17p, and 18cen. Moreover, a 4- to 6-fold gain of sequences on 18q leads to a low-level amplification of the BCL2 gene and to an overexpression of the BCL2 protein. These results provide the basis for the identification of not only candidate oncogenes responsible for MCL in gained regions, but also for the identification of putative tumor suppressor genes in commonly deleted regions like 1p22, which would eventually enable functional studies of these genes. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 23 条
[1]   Incidence of homogeneously staining regions in non-Hodgkin lymphomas [J].
Arranz, E ;
Robledo, M ;
Martinez, B ;
Gallego, J ;
Roman, A ;
Rivas, C ;
Benitez, J .
CANCER GENETICS AND CYTOGENETICS, 1996, 87 (01) :1-3
[2]   COMPARATIVE GENOMIC HYBRIDIZATION IN CHRONIC B-CELL LEUKEMIAS SHOWS A HIGH-INCIDENCE OF CHROMOSOMAL GAINS AND LOSSES [J].
BENTZ, M ;
HUCK, K ;
DUMANOIR, S ;
JOOS, S ;
WERNER, CA ;
FISCHER, K ;
DOHNER, H ;
LICHTER, P .
BLOOD, 1995, 85 (12) :3610-3618
[3]  
Bentz M, 2000, GENE CHROMOSOME CANC, V27, P285, DOI 10.1002/(SICI)1098-2264(200003)27:3<285::AID-GCC9>3.3.CO
[4]  
2-D
[5]   GENE AMPLIFICATION IN NON-HODGKINS-LYMPHOMA [J].
BENYEHUDA, D ;
HOULDSWORTH, J ;
PARSA, NZ ;
CHAGANTI, RSK .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (04) :792-797
[6]   CYCLIN D1 TRANSGENE IMPEDES LYMPHOCYTE MATURATION AND COLLABORATES IN LYMPHOMAGENESIS WITH THE MYC GENE [J].
BODRUG, SE ;
WARNER, BJ ;
BATH, ML ;
LINDEMAN, GJ ;
HARRIS, AW ;
ADAMS, JM .
EMBO JOURNAL, 1994, 13 (09) :2124-2130
[7]   High resolution multicolor-banding:: a new technique for refined FISH analysis of human chromosomes [J].
Chudoba, I ;
Plesch, A ;
Lörch, T ;
Lemke, J ;
Claussen, U ;
Senger, G .
CYTOGENETICS AND CELL GENETICS, 1999, 84 (3-4) :156-160
[8]  
Dreyling MH, 1997, CANCER RES, V57, P4608
[9]   Potential role for concurrent abnormalities of the cyclin D1, p16(CDKN2) and p15(CDKN2B) genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519) [J].
Jadayel, DM ;
Lukas, J ;
Nacheva, E ;
Bartkova, J ;
Stranks, G ;
DeSchouwer, PJJC ;
Lens, D ;
Bartek, J ;
Dyer, MJS ;
Kruger, AR ;
Catovsky, D .
LEUKEMIA, 1997, 11 (01) :64-72
[10]  
Liehr T, 2002, INT J MOL MED, V9, P335